- Nov 3, 2022
Study offers proof of concept for treating pediatric brain tumors with immunotherapy
Now, in a new proof-of-concept study published in the Journal for ImmunoTherapy of Cancer, researchers at Children's Hospital of...
- Nov 2, 2022
3D genomics reveals targets for aggressive childhood cancers
While some pediatric brain cancers have known genetic causes, many do not. Three-dimensional profiling revealed new disease mechanisms...
- Oct 31, 2022
A stem cell protein facilitates relapse of pediatric brain tumors
The malignant brain tumor type medulloblastoma can become resistant to therapy which can cause relapse. Researchers have discovered a...
- Oct 13, 2022
Childhood cancer radiotherapy involving exposure to the head increases risk of future brain tumours
Children who received radiotherapy which exposed their head are at increased risk of developing a type of brain tumour called a...
- Jul 18, 2022
Brain Cancer Therapy Shows Promise in Pediatric Clinical Trial
A new antibody therapy for children with medulloblastoma has shown promise during a Phase I clinical trial. The antibody, which targets a...
- Jun 6, 2022
Engineers develop nanoparticles that cross the blood-brain barrier
Tested using a new brain tissue model, the particles may be able to deliver chemotherapy drugs for glioblastoma. Read more:...
- Apr 26, 2022
Study finds jumping 'junk' DNA is a novel cause of childhood brain cancer
Scientists have found a novel cause of aggressive pediatric brain cancer. The St. Jude Children's Research Hospital study is the first to...
- Mar 30, 2022
Youngest brain tumor patients have significantly poorer outcomes than older pediatric patients
A researcher has found, through extensive data analysis, that the youngest patients with brain tumors -- those ages birth to 3 months...